April 7, 2003

Boehringer Ingelheim Pharmaceuticals holds grand opening at the Virginia BioTechnology Research Park

Share this story

Michael J. Schewel (right), secretary of commerce & trade for the Commonwealth of Virginia, and Thomas Huff (left), vice provost for Life Sciences at Virginia Commonwealth University were among approximately 40 guests who attended Boehringer Ingelheim Pharmaceutical’s grand opening at the Virginia BioTechnology Research Park on March 28. BI Pharmaceuticals moved into its 6,540 square-foot, research-and-development laboratory in July 2002, joining sister company BI Chemicals, which has been a tenant of the park since 1996. The German company’s U.S. headquarters is in Connecticut. Photo by Allen Jones, VCU Creative Services
Michael J. Schewel (right), secretary of commerce & trade for the Commonwealth of Virginia, and Thomas Huff (left), vice provost for Life Sciences at Virginia Commonwealth University were among approximately 40 guests who attended Boehringer Ingelheim Pharmaceutical’s grand opening at the Virginia BioTechnology Research Park on March 28. BI Pharmaceuticals moved into its 6,540 square-foot, research-and-development laboratory in July 2002, joining sister company BI Chemicals, which has been a tenant of the park since 1996. The German company’s U.S. headquarters is in Connecticut. Photo by Allen Jones, VCU Creative Services